

NCT03337503 comparison:

Summary:
CHIA has 26 criteria while your personal folder has 26 criteria
Total found criteria: 26/26
Total not Found: 0/26
Total Extra: 4
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Written informed consent                           │ Written informed consent                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Adult patients (older than 18 years of age), male  │ Adult patients (older than 18 years of age), male  │
│ and female, with chronic non-cancer and cancer     │ and female, with chronic non-cancer and cancer     │
│ pain (at least 3 months in duration)               │ pain (at least 3 months in duration)               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients experiencing an average weekly pain       │ Patients experiencing an average weekly pain       │
│ intensity score greater than 4 on a 11 points NRS  │ intensity score greater than 4 on a 11 points NRS  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Subject agreed to follow the protocol              │ Subject agreed to follow the protocol              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Naïve cannabis patients with chronic non-cancer    │ Naïve cannabis patients with chronic non-cancer    │
│ and cancer pain (not used cannabis in any          │ and cancer pain (not used cannabis in any          │
│ presentation in the last 12 weeks)                 │ presentation in the last 12 weeks)                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients receiving opioids and other concomitant   │ Patients receiving opioids and other concomitant   │
│ pain medications should have a stable dose for the │ pain medications should have a stable dose for the │
│ last 15 days                                       │ last 15 days                                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Normal cognitive status according to MiniCog       │ Normal cognitive status according to MiniCog       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Normal liver function (defined as aspartate        │ Normal liver function (defined as aspartate        │
│ aminotransferase 10-40 U/L and alanine             │ aminotransferase 10-40 U/L and alanine             │
│ aminotransferase 7-56 U/L)                         │ aminotransferase 7-56 U/L)                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Normal renal function (defined as serum creatinine │ Normal renal function (defined as serum creatinine │
│ level <133 µmol/L and Estimated Glomerular         │ level \<133 µmol/L and Estimated Glomerular        │
│ Filtration Rate (eGFR) greater than or equal to    │ Filtration Rate (eGFR) greater than or equal to    │
│ 60)                                                │ 60)                                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Negative result on ßhuman chorionic gonadotropin   │ Negative result on βhuman chorionic gonadotropin   │
│ pregnancy test (if applicable)                     │ pregnancy test (if applicable)                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Ability to read and respond to questions in French │ Ability to read and respond to questions in French │
│ or English                                         │ or English                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ A male volunteer with sexual partners who are      │ A male volunteer with sexual partners who are      │
│ pregnant, possibly pregnant, or who could become   │ pregnant, possibly pregnant, or who could become   │
│ pregnant must be surgically sterile or agrees to   │ pregnant must be surgically sterile or agrees to   │
│ use one of the accepted contraceptive regimens     │ use one of the accepted contraceptive regimens     │
│ from first drug administration until 3 months      │ from first drug administration until 3 months      │
│ after the last drug administration                 │ after the last drug administration                 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Acute pain (less than 3 months in duration)        │ Acute pain (less than 3 months in duration)        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Previous serious adverse event or hypersensitivity │ Previous serious adverse event or hypersensitivity │
│ to cannabis or cannabinoids                        │ to cannabis or cannabinoids                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Inability to understand and comply with the        │ Inability to understand and comply with the        │
│ instructions of the study                          │ instructions of the study                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Presence of significant cardiac disease (history   │ Presence of significant cardiac disease (history   │
│ of unstable ischemic heart disease, heart failure, │ of unstable ischemic heart disease, heart failure, │
│ severe and uncontrolled hypertension) that, in the │ severe and uncontrolled hypertension) that, in the │
│ opinion of the investigator, would put the patient │ opinion of the investigator, would put the patient │
│ at risk of a clinically significant arrhythmia or  │ at risk of a clinically significant arrhythmia or  │
│ myocardial infarction                              │ myocardial infarction                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current substance use disorder according to the    │ Current substance use disorder according to the    │
│ Diagnostic and Statistical Manual of Mental        │ Diagnostic and Statistical Manual of Mental        │
│ Disorders Fifth Edition (DSM 5)                    │ Disorders Fifth Edition (DSM 5)                    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Life-time history of dependence on cannabis or     │ Life-time history of dependence on cannabis or     │
│ diagnosis of cannabis use disorder (CUD) according │ diagnosis of cannabis use disorder (CUD) according │
│ to the DSM 5                                       │ to the DSM 5                                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Life-time history of DSM 5 schizophrenia, bipolar  │ Life-time history of DSM 5 schizophrenia, bipolar  │
│ disorder, or previous psychosis with or            │ disorder, or previous psychosis with or            │
│ intolerance to cannabinoids                        │ intolerance to cannabinoids                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current or history of suicidal ideation            │ Current or history of suicidal ideation            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnant, breast-feeding or female patients of     │ Pregnant, breast-feeding or female patients of     │
│ child-bearing potential and male patients whose    │ child-bearing potential and male patients whose    │
│ partner is of child-bearing potential, unless      │ partner is of child-bearing potential, unless      │
│ willing to ensure that they or their partner use   │ willing to ensure that they or their partner use   │
│ effective contraception                            │ effective contraception                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Hepatic impairment (aspartate aminotransferase     │ Hepatic impairment (aspartate aminotransferase     │
│ more than three times normal) or renal function    │ more than three times normal) or renal function    │
│ impairment (serum creatinine level >133 µmol/L,    │ impairment (serum creatinine level \>133 µmol/L,   │
│ Estimated Glomerular Filtration Rate (eGFR) <60)   │ Estimated Glomerular Filtration Rate (eGFR) \<60)  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Cognitive impairment according to MiniCog          │ Cognitive impairment according to MiniCog          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ The patient is currently using or has used         │ The patient is currently using or has used         │
│ cannabinoid based medications within 90 days of    │ cannabinoid based medications within 90 days of    │
│ study entry and is unwilling to abstain for the    │ study entry and is unwilling to abstain for the    │
│ duration of the study                              │ duration of the study                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Positive urine drug screen for cannabinoids and    │ Positive urine drug screen for cannabinoids and    │
│ other potential abuse substances (e.g. alcohol,    │ other potential abuse substances (e.g. alcohol,    │
│ cocaine, amphetamines and methamphetamines,        │ cocaine, amphetamines and methamphetamines,        │
│ unprescribed opioids)                              │ unprescribed opioids)                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Participation in another clinical trial within 30  │ Participation in another clinical trial within 30  │
│ days of enrolment in our trial                     │ days of enrolment in our trial                     │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                         │
╞═════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Must have minimum age of 18 Years                                                               │
├─────────────────────────────────────────────────────────────────────────────────────────────────┤
│ A female volunteer must meet one of the following criteria                                      │
├─────────────────────────────────────────────────────────────────────────────────────────────────┤
│ If of non-childbearing potential - should be surgically sterile or in a menopausal state        │
├─────────────────────────────────────────────────────────────────────────────────────────────────┤
│ If of childbearing potential - agrees to use one of the accepted contraceptive regimens from at │
│ least 28 days prior to the first drug administration, during the study and for at least 60 days │
│ after the last dose                                                                             │
╘═════════════════════════════════════════════════════════════════════════════════════════════════╛